213 related articles for article (PubMed ID: 10585416)
21. Sterol Carrier Protein-2, a Nonspecific Lipid-Transfer Protein, in Intracellular Cholesterol Trafficking in Testicular Leydig Cells.
Li NC; Fan J; Papadopoulos V
PLoS One; 2016; 11(2):e0149728. PubMed ID: 26901662
[TBL] [Abstract][Full Text] [Related]
22. Biogenesis of nonspecific lipid transfer protein and sterol carrier protein x: studies using peroxisome assembly-defective pex cell mutants.
Otera H; Nishimura M; Setoguchi K; Mori T; Fujiki Y
J Biol Chem; 2001 Jan; 276(4):2858-64. PubMed ID: 11042217
[TBL] [Abstract][Full Text] [Related]
23. Identification of the newly discovered 58 kDa peroxisomal thiolase SCPx as the main thiolase involved in both pristanic acid and trihydroxycholestanoic acid oxidation: implications for peroxisomal beta-oxidation disorders.
Wanders RJ; Denis S; van Berkel E; Wouters F; Wirtz KW; Seedorf U
J Inherit Metab Dis; 1998 Jun; 21(3):302-5. PubMed ID: 9686381
[No Abstract] [Full Text] [Related]
24. Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A are markedly up-regulated in Cyp27-/- mice but not in cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
J Biol Chem; 2001 Sep; 276(37):34579-85. PubMed ID: 11454857
[TBL] [Abstract][Full Text] [Related]
25. SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects.
Galano M; Ezzat S; Papadopoulos V
Hum Genomics; 2022 Aug; 16(1):32. PubMed ID: 35996156
[TBL] [Abstract][Full Text] [Related]
26. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid.
Axelson M; Ellis E; Mörk B; Garmark K; Abrahamsson A; Björkhem I; Ericzon BG; Einarsson C
Hepatology; 2000 Jun; 31(6):1305-12. PubMed ID: 10827156
[TBL] [Abstract][Full Text] [Related]
27. Effect of the side-chain structure on the specificity of beta-oxidation in bile acid biosynthesis in rat liver homogenates.
Kurosawa T; Sato M; Watanabe T; Suga T; Tohma M
J Lipid Res; 1997 Dec; 38(12):2589-602. PubMed ID: 9458282
[TBL] [Abstract][Full Text] [Related]
28. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.
Atshaves BP; McIntosh AL; Landrock D; Payne HR; Mackie JT; Maeda N; Ball J; Schroeder F; Kier AB
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G939-51. PubMed ID: 17068117
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of coenzyme A esters of 3alpha,7alpha,12alpha-trihydroxy- and 3alpha,7alpha-dihydroxy-24-oxo-5beta-cholestan-26-oic acids for the study of beta-oxidation in bile acid biosynthesis.
Kurosawa T; Fujiwara M; Nakano H; Sato M; Yoshimura T; Murai T
Steroids; 2001 Jun; 66(6):499-504. PubMed ID: 11182138
[TBL] [Abstract][Full Text] [Related]
30. Human sterol carrier protein x/sterol carrier protein 2 gene has two promoters.
Ohba T; Holt JA; Billheimer JT; Strauss JF
Biochemistry; 1995 Aug; 34(33):10660-8. PubMed ID: 7654720
[TBL] [Abstract][Full Text] [Related]
31. Participation of two members of the very long-chain acyl-CoA synthetase family in bile acid synthesis and recycling.
Mihalik SJ; Steinberg SJ; Pei Z; Park J; Kim DG; Heinzer AK; Dacremont G; Wanders RJ; Cuebas DA; Smith KD; Watkins PA
J Biol Chem; 2002 Jul; 277(27):24771-9. PubMed ID: 11980911
[TBL] [Abstract][Full Text] [Related]
32. Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid.
Ferdinandusse S; Denis S; Mooijer PA; Zhang Z; Reddy JK; Spector AA; Wanders RJ
J Lipid Res; 2001 Dec; 42(12):1987-95. PubMed ID: 11734571
[TBL] [Abstract][Full Text] [Related]
33. Inborn errors of bile acid metabolism.
Clayton PT
J Inherit Metab Dis; 1991; 14(4):478-96. PubMed ID: 1749214
[TBL] [Abstract][Full Text] [Related]
34. Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism.
Fuchs M; Hafer A; Münch C; Kannenberg F; Teichmann S; Scheibner J; Stange EF; Seedorf U
J Biol Chem; 2001 Dec; 276(51):48058-65. PubMed ID: 11673458
[TBL] [Abstract][Full Text] [Related]
35. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
[TBL] [Abstract][Full Text] [Related]
36. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
37. Anomalous enantioselectivity in the sharpless asymmetric dihydroxylation reaction of 24-nor-5beta-cholest-23-ene-3alpha,7alpha,12alpha-triol: synthesis of substrates for studies of cholesterol side-chain oxidation.
Ertel NH; Dayal B; Rao K; Salen G
Lipids; 1999 Apr; 34(4):395-405. PubMed ID: 10443973
[TBL] [Abstract][Full Text] [Related]
38. Sterol carrier protein-2: structure reveals function.
Stolowich NJ; Petrescu AD; Huang H; Martin GG; Scott AI; Schroeder F
Cell Mol Life Sci; 2002 Feb; 59(2):193-212. PubMed ID: 11915938
[TBL] [Abstract][Full Text] [Related]
39. The catabolism of cholesterol in vitro. Formation of 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoic acid from cholesterol by rat liver.
Mendelsohn D; Mendelsohn L
Biochem J; 1969 Aug; 114(1):1-3. PubMed ID: 5810058
[TBL] [Abstract][Full Text] [Related]
40. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
Setoguchi T; Salen G; Tint GS; Mosbach EH
J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
